ORE001

Orexa BV · Phase 2 active Small molecule

At a glance

Generic name	ORE001
Also known as	Lidocaine
Sponsor	Orexa BV
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy. (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ORE001 CI brief — competitive landscape report
ORE001 updates RSS · CI watch RSS
Orexa BV portfolio CI